United Therapeutics Corp (UTHR)

Jul 21, 2025

United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag - Insider Monkey

Jul 21, 2025

Jul 20, 2025

What analysts say about United Therapeutics Corporation stockConsistent triple returns - jammulinksnews.com

Jul 20, 2025

Jul 19, 2025

Is United Therapeutics Corporation a good long term investmentBreakthrough profit margins - jammulinksnews.com

Jul 19, 2025

Jul 19, 2025

United Therapeutics Corporation Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

What drives United Therapeutics Corporation stock priceSkyrocketing investment returns - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

Morgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating - Insider Monkey

Jul 18, 2025

Jul 18, 2025

Here's Why United Therapeutics (UTHR) is a Strong Value Stock - Yahoo Finance

Jul 18, 2025

Jul 17, 2025

Pulmonary Arterial Hypertension Market Forecast 2034: - openPR.com

Jul 17, 2025

Jul 17, 2025

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Jul 17, 2025

Jul 17, 2025

Pulmonary Arterial Hypertension Drug Market Forecast to 2032: - openPR.com

Jul 17, 2025

Jul 16, 2025

United Therapeutics Announces Q2 Earnings Date: Key Details for Biotech Investment Community - Stock Titan

Jul 16, 2025

Jul 16, 2025

Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest - Yahoo Finance

Jul 16, 2025

Jul 15, 2025

Oppenheimer Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $510 - 富途牛牛

Jul 15, 2025

Jul 15, 2025

Reflecting On Therapeutics Stocks' Q1 Earnings: Moderna (NASDAQ:MRNA) - FinancialContent

Jul 15, 2025

Jul 15, 2025

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment - Yahoo Finance

Jul 15, 2025

Jul 14, 2025

United Therapeutics Puts Big Bets On Tyvaso’s Trial Results - Finimize

Jul 14, 2025

Jul 14, 2025

United Therapeutics Offers Favorable Profile Ahead of Key Data, Oppenheimer Says - MarketScreener

Jul 14, 2025

Jul 14, 2025

United Therapeutics (UTHR) Awaits Key Catalyst with Positive Ris - GuruFocus

Jul 14, 2025

Jul 14, 2025

United Therapeutic's: The Brands First Hydrogen Helicopter - Energy Digital Magazine

Jul 14, 2025

Jul 11, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis - TipRanks

Jul 11, 2025

Jul 11, 2025

Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 11, 2025

Jul 11, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors - TipRanks

Jul 11, 2025

Jul 10, 2025

UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) - Insider Monkey

Jul 10, 2025

Jul 10, 2025

United Therapeutics (UTHR) Price Target Adjustment by Morgan Sta - GuruFocus

Jul 10, 2025

Jul 10, 2025

United Therapeutics (UTHR) Price Target Trimmed by Morgan Stanle - GuruFocus

Jul 10, 2025

Jul 09, 2025

United Therapeutics' Inhaled Treprostinil Study for Pulmonary Fibrosis: Key Insights for Investors - AInvest

Jul 09, 2025

Jul 08, 2025

United Therapeutics (UTHR): JP Morgan Adjusts Price Target | UTH - GuruFocus

Jul 08, 2025

Jul 04, 2025

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 04, 2025

Jul 01, 2025

United Therapeutics Faces Key Moment With Tyvaso's Q3 Results - Finimize

Jul 01, 2025

Jun 30, 2025

United Therapeutics (UTHR) Maintains Buy Rating, Price Target Lowered by UBS | UTHR Stock News - GuruFocus

Jun 30, 2025

Jun 30, 2025

United Therapeutics’ Promising Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Jun 30, 2025

Jun 30, 2025

United Therapeutics (UTHR) Maintains Buy Rating, Price Target Lo - GuruFocus

Jun 30, 2025

Jun 28, 2025

United Therapeutics Announces World’s First Bioengineered External Liver Treatment in Clinical Study - Yahoo Finance

Jun 28, 2025

Jun 27, 2025

United Therapeutics EVP Mahon sells $3.14 million in UTHR stock - Investing.com

Jun 27, 2025

Jun 26, 2025

United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment - TipRanks

Jun 26, 2025

Jun 25, 2025

Nilda Mesa, United Therapeutics director, sells $187k in stock - Investing.com

Jun 25, 2025

Jun 24, 2025

United Therapeutics (UTHR) Begins Groundbreaking Clinical Study with miroliverELAP | UTHR Stock News - GuruFocus

Jun 24, 2025

Jun 23, 2025

Pulmonary Arterial Hypertension Market Set to Grow Substantially Through 2034, DelveInsight Projects | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros - Barchart.com

Jun 23, 2025

Jun 17, 2025

United Therapeutics delivers 18th consecutive quarter of topline growth - MarketScreener

Jun 17, 2025

Jun 16, 2025

United Therapeutics EVP Paul Mahon sells $3.08m in stock By Investing.com - Investing.com Canada

Jun 16, 2025

Jun 16, 2025

United Therapeutics Insider Sold Shares Worth $3,079,514, According to a Recent SEC Filing - MarketScreener

Jun 16, 2025

Jun 16, 2025

United Therapeutics EVP Paul Mahon sells $3.08m in stock - Investing.com

Jun 16, 2025

Jun 15, 2025

AppLovin, Chewy And Carvana Are Among Top 11 Large Cap Losers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga

Jun 15, 2025

Jun 13, 2025

United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock? - Yahoo Finance

Jun 13, 2025

Jun 11, 2025

United Therapeutics (UTHR) Maintains Neutral Rating, Price Targe - GuruFocus

Jun 11, 2025

Jun 11, 2025

United Therapeutics: Tanking On Rival's PAH DataI'd Consider Buying Stock (NASDAQ:UTHR) - Seeking Alpha

Jun 11, 2025

Jun 10, 2025

Insmed Shares Rise After Phase 2b Trial of Treprostinil Inhalation Powder in PAH Meets Endpoints - marketscreener.com

Jun 10, 2025

Jun 10, 2025

United Therapeutics (UTHR) Stock Plummets Over 15% in Major Sell-Off - Daily Chhattisgarh News

Jun 10, 2025

Jun 10, 2025

Liquidia, United Therapeutics fall after mid-stage data for Insmed’s PAH asset - Seeking Alpha

Jun 10, 2025

Jun 06, 2025

Treprostinil Saga Continues - JD Supra

Jun 06, 2025

Jun 06, 2025

United Therapeutics president sells shares worth $3.7 million - MSN

Jun 06, 2025

Jun 04, 2025

Leerink Partners maintains positive outlook on United Therapeutics stock By Investing.com - Investing.com South Africa

Jun 04, 2025